PINC

Premier Inc. (PINC) | Rumor.io

Premier

PINC

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio289.7

Market capitalization4.1B

Earnings per share0.22

Dividend yield (TTM)1.71%

Revenue (annual)1B

Net income (annual)30.8M

Social

What share of all stock conversation is about PINC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Sep 22

Premier, Inc. ($PINC) has agreed to be acquired by Patient Square Capital in a $2.6 billion all-cash deal, with shareholders receiving $28.25 per share, a 23.8% premium to the 60-day VWAP.
The acquisition is expected to close by the first quarter of 2026, with Premier going private and receiving new capital to boost its technology and services for hospitals and health systems.
The deal values Premier at approximately $2.6 billion, with the company's stock trading higher following the announcement.

Generated by AI

Sentiment

Of the messages about PINC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	91.67% +41.67
Bearish	—	—	—	8.33% -41.67

Aug 22

Premier Inc.'s stock price has seen significant gains, increasing by 14.6% on Tuesday.
Multiple analysts have raised their price targets for PINC, with Oppenheimer setting a target of $48.00 and Benchmark Co. setting a target of $50.00.
Analysts from firms such as Leerink Partners, Raymond James, and Benchmark Co. have reiterated their "buy" or "outperform" ratings on PINC, with price targets ranging from $42.00 to $55.00.

Generated by AI

Topics

Of the messages about PINC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	3.44%
Announcements	—	—	—	69.34%
Controversies	—	—	—	3.44%
Earnings	—	—	—	18.05%
Macro	—	—	—	1.15%
Technical Analysis	—	—	—	4.58%

Earnings· Feb 7

Premier Inc. reported Q2 earnings of $0.72 per share, beating estimates of $0.66.
Revenue for Q2 was $359.63M, exceeding expectations of $351.5M.
Premier reaffirmed its FY23 revenue guidance and updated its FY23 EPS guidance to $2.53-$2.65.

Analysts· Aug 22

Premier, Inc. ($PINC) price target increased to $48.00 by Oppenheimer analysts.
Raymond James reiterates "Outperform" rating on Premier, Inc. ($PINC) with a $49 price target.
Leerink Swann analysts give Premier, Inc. ($PINC) a $55.00 price target.

Announcements· Sep 22

Premier, Inc. ($PINC) has agreed to be acquired by private equity firm Patient Square Capital in a $2.6 billion all-cash deal, with shareholders receiving $28.25 per share, a 23.8% premium to the 60-day VWAP.
The acquisition is expected to close by the first quarter of 2026, with Premier stockholders receiving $28.25 in cash per share, representing a premium of 9.71% from the stock’s last close.
The deal will take Premier, Inc. private, with Patient Square Capital providing new capital to boost the company's technology and services for hospitals and health systems.

Technical Analysis· May 7

The asset PINC is forming a Head and Shoulders (H&S) pattern with a potential short signal from the current level to $27.57.
The H&S formation is breaking down, indicating a potential bearish trend.
The pattern suggests a possible reversal of the asset's price trend.

Generated by AI

Community

Of the messages about PINC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	21.95%
Newcomers	—	—	—	78.05%

Regulars· Aug 19

Premier, Inc. reported a non-GAAP EPS of $0.46, beating estimates by $0.12, and revenue of $257.97M, beating estimates by $10.29M.
The company's fiscal-year 2025 fourth-quarter and full-year financial results showed a 37.68% YoY decline in adjusted EPS and a 24.96% YoY decline in sales.
Premier, Inc. provided FY2026 guidance, expecting adjusted EPS of $1.37-$1.43 and sales of $955M-$995M, which is slightly below estimates.

Newcomers· Sep 22

The acquisition of Premier, Inc. by Patient Square Capital is valued at $2.6 billion, with shareholders receiving $28.25 per share in cash.
The deal represents a 23.8% premium to the 60-day VWAP, with the merger expected to close in Q1 2026.
Premier, Inc.'s adjusted EBITDA and income have seen year-over-year declines, with management and board credibility being a concern for investors.

Generated by AI

Quanta Dialysis Technologies® today announced that it will be honored during Premier's annual Supplier Innovation Celebration at its 2026 Breakthroughs Conference and Exhibition, which is scheduled to take place October 6-8 at the Gaylord National Resort & Convention Center in National Harbor, MD. The Innovation Celebration recognizes groundbreaking healthcare technologies launched throughout the year and highlights how these products help improve the health of communities.

19d agoYahoo Finance

Blue Sky Capital Strategies, LLC awarded Leasing and Financial Services agreement with Premier Inc

Blue Sky Capital Strategies, LLC, a specialized advisory firm in equipment leasing and equipment financing announced its continued focus on helping organizations reduce costs, improve financial flexibility and mitigate risk through experienced lease structuring, contract negotiations and financing advisory services has been awarded a national group purchasing agreement for Leasing and Financial Services with Premier, Inc. effective July 1, 2026.

1mo agoYahoo Finance Singapore

BRIJ Medical Awarded Breakthrough Technology Designation for BRIJ-SEAL™ Advanced Wound Sealant with Premier, Inc.

BRIJ Medical, Inc., a medical device company advancing surgical incision management through innovative wound closure technologies, today announced a new Breakthrough Technology designation with Premier, Inc. Premier offers Breakthrough Technology designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes and operational efficiencies.

2mo agoYahoo Finance Singapore

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

WAYNE, Pa., July 21, 2026--Teleflex Incorporated (NYSE: TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products, including short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions.

2mo agoYahoo Finance

Mercury Medical Awarded Respiratory Therapy, Resuscitation Devices Agreement with Premier, Inc.

CLEARWATER, FL / ACCESS Newswire / July 21, 2026 / Mercury Medical has been awarded a national group purchasing agreement for respiratory therapy, resuscitation devices with Premier, Inc. Effective September 1st, 2026, the new agreement allows Premier ...

2mo agoYahoo Finance

Also Discussed

Investors talking about PINC also mention

#	Name	Attention
1	AB Conservative Buffer ETFBUFC	0%0
2	Defiance Daily Target 2X Long ANET ETFANEL	0.02%new
3	Pacer Nasdaq-100 Top 50 Cash Cows Growth Leaders ETFQQQG	0%0
4	A SPAC III Acquisition Corp.ASPCU	0%0
5	Level Four Large Cap Growth Active ETFLGRO	0%0
6	Nuveen Preferred and Income ETFNPFI	0%0
7	US Treasury 20 Year Bond ETFUTWY	0%0
8	Avantis U.S. Quality ETFAVUQ	-0%0
9	Peoples Bancorp of North Carolina, Inc.PEBK	0%0
10	Leverage Shares 2X Long RTX Daily ETFRTXG	0%0

Premier Inc.

Healthcare
Health Information Services

Premier Inc. is a leading healthcare improvement company that collaborates with healthcare providers to optimize clinical, financial, and operational outcomes. The company's primary function is to transform the quality of healthcare delivery by leveraging integrated data analytics, consulting, and services. Premier Inc. serves a pivotal role in the healthcare sector, impacting hospitals, health systems, and other medical providers by providing them with tools and solutions necessary to improve patient care and reduce costs. Premier's comprehensive offerings include supply chain services, performance improvement programs, and advisory services, catering to the urgent needs of healthcare institutions striving for excellence in service delivery. By harnessing its vast network of provider members, Premier pioneers advancements in areas such as value-based care, population health management, and regulatory compliance. The company's initiatives contribute significantly to setting industry standards and driving innovation across the healthcare continuum, distinguishing it as a crucial player in enhancing the efficiency and effectiveness of healthcare in the United States.

Website

Location

13520 Ballantyne Corporate Place

Charlotte, NC, 28277

United States

Social

What share of all stock conversation is about PINC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Sep 22

Premier, Inc. ($PINC) has agreed to be acquired by Patient Square Capital in a $2.6 billion all-cash deal, with shareholders receiving $28.25 per share, a 23.8% premium to the 60-day VWAP.
The acquisition is expected to close by the first quarter of 2026, with Premier going private and receiving new capital to boost its technology and services for hospitals and health systems.
The deal values Premier at approximately $2.6 billion, with the company's stock trading higher following the announcement.

Generated by AI

Sentiment

Of the messages about PINC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	91.67% +41.67
Bearish	—	—	—	8.33% -41.67

Aug 22

Premier Inc.'s stock price has seen significant gains, increasing by 14.6% on Tuesday.
Multiple analysts have raised their price targets for PINC, with Oppenheimer setting a target of $48.00 and Benchmark Co. setting a target of $50.00.
Analysts from firms such as Leerink Partners, Raymond James, and Benchmark Co. have reiterated their "buy" or "outperform" ratings on PINC, with price targets ranging from $42.00 to $55.00.

Generated by AI

Topics

Of the messages about PINC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	3.44%
Announcements	—	—	—	69.34%
Controversies	—	—	—	3.44%
Earnings	—	—	—	18.05%
Macro	—	—	—	1.15%
Technical Analysis	—	—	—	4.58%

Earnings· Feb 7

Premier Inc. reported Q2 earnings of $0.72 per share, beating estimates of $0.66.
Revenue for Q2 was $359.63M, exceeding expectations of $351.5M.
Premier reaffirmed its FY23 revenue guidance and updated its FY23 EPS guidance to $2.53-$2.65.

Analysts· Aug 22

Premier, Inc. ($PINC) price target increased to $48.00 by Oppenheimer analysts.
Raymond James reiterates "Outperform" rating on Premier, Inc. ($PINC) with a $49 price target.
Leerink Swann analysts give Premier, Inc. ($PINC) a $55.00 price target.

Announcements· Sep 22

Premier, Inc. ($PINC) has agreed to be acquired by private equity firm Patient Square Capital in a $2.6 billion all-cash deal, with shareholders receiving $28.25 per share, a 23.8% premium to the 60-day VWAP.
The acquisition is expected to close by the first quarter of 2026, with Premier stockholders receiving $28.25 in cash per share, representing a premium of 9.71% from the stock’s last close.
The deal will take Premier, Inc. private, with Patient Square Capital providing new capital to boost the company's technology and services for hospitals and health systems.

Technical Analysis· May 7

The asset PINC is forming a Head and Shoulders (H&S) pattern with a potential short signal from the current level to $27.57.
The H&S formation is breaking down, indicating a potential bearish trend.
The pattern suggests a possible reversal of the asset's price trend.

Generated by AI

Community

Of the messages about PINC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	21.95%
Newcomers	—	—	—	78.05%

Regulars· Aug 19

Premier, Inc. reported a non-GAAP EPS of $0.46, beating estimates by $0.12, and revenue of $257.97M, beating estimates by $10.29M.
The company's fiscal-year 2025 fourth-quarter and full-year financial results showed a 37.68% YoY decline in adjusted EPS and a 24.96% YoY decline in sales.
Premier, Inc. provided FY2026 guidance, expecting adjusted EPS of $1.37-$1.43 and sales of $955M-$995M, which is slightly below estimates.

Newcomers· Sep 22

The acquisition of Premier, Inc. by Patient Square Capital is valued at $2.6 billion, with shareholders receiving $28.25 per share in cash.
The deal represents a 23.8% premium to the 60-day VWAP, with the merger expected to close in Q1 2026.
Premier, Inc.'s adjusted EBITDA and income have seen year-over-year declines, with management and board credibility being a concern for investors.

Generated by AI

Premier

Social

Sep 22

Aug 22

Earnings· Feb 7

Analysts· Aug 22

Announcements· Sep 22

Technical Analysis· May 7

Regulars· Aug 19

Newcomers· Sep 22

QUANTA DIALYSIS TECHNOLOGIES, INC. TO BE HONORED AT PREMIER, INC.'S ANNUAL SUPPLIER INNOVATION CELEBRATION

Blue Sky Capital Strategies, LLC awarded Leasing and Financial Services agreement with Premier Inc

BRIJ Medical Awarded Breakthrough Technology Designation for BRIJ-SEAL™ Advanced Wound Sealant with Premier, Inc.

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Mercury Medical Awarded Respiratory Therapy, Resuscitation Devices Agreement with Premier, Inc.

Also Discussed

Premier Inc.

Company Information

Location

QUANTA DIALYSIS TECHNOLOGIES, INC. TO BE HONORED AT PREMIER, INC.'S ANNUAL SUPPLIER INNOVATION CELEBRATION

Blue Sky Capital Strategies, LLC awarded Leasing and Financial Services agreement with Premier Inc

BRIJ Medical Awarded Breakthrough Technology Designation for BRIJ-SEAL™ Advanced Wound Sealant with Premier, Inc.

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Mercury Medical Awarded Respiratory Therapy, Resuscitation Devices Agreement with Premier, Inc.

Also Discussed

Social

Sep 22

Aug 22

Earnings· Feb 7

Analysts· Aug 22

Announcements· Sep 22

Technical Analysis· May 7

Regulars· Aug 19

Newcomers· Sep 22